Pinocembrin, a flavonoid from propolis, is shown to affect cardiovascular diseases based on its ability to regulate apolipoprotein E (ApoE; a protein involved in the metabolism of fats) and reduce rho kinase (regulates shape and movement of cells) [115]. This evidence concerns the gene APOE and cardiovascular disorder.